Added to your cart


Cart subtotal: £0.00

View cart (0) Checkout


Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Ribonuclease (RNase) is classified as an endonuclease, which specifically cleaves phosphodiester bonds at the 3’-end of pyrimidine nucleosides and at the 5’-ribose of a nucleotide, ribonucleic acid (RNA). Ribonuclease can be used in the following applications: + In isolation of DNA for RNA-free DNA, especially plasmid DNA + Structural studies of RNA + The depolymerisation of viscous biological suspensions, rendering RNA-free solutions

More information



  • Abbreviations
  • Rnase
  • Lead Time
  • 12 weeks
  • Storage
  • Store desiccated at -15°C or below. Allow to come
  • Shelf Life
  • 10 years
  • Manufacturer Country
  • UK
  • Source
  • Bovine pancreas
  • Activity
  • ≥70U/mg material (RNase A content approximately 70%)
  • EC Number
  • Solubility
  • Dissolves readily at 2 mg/ml in analytical grade water to give a clear solution.
  • Systematic Name
  • Ribonucleate 3’-pyrimidino-oligonucleotidohydrolase
  • Unit Definition
  • That amount of enzyme causing the hydrolysis of RNA at a rate such that k (velocity constant) equals unity (Kunitz units) at 25C and pH 5.0.

Technical Documents

Product Specification (106.08KB)

Analytical Procedures (136.03KB)

Product Information (352.7KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox